#SurfBio
#HalozymeTherapeutics has expanded its portfolio of #drugdeliverytechnologies for a second time in a few months with the #acquisition of #SurfBio and its subcutaneous injection platform.

pharmaphorum.com/news/halozym...
Halozyme diversifies in drug delivery with Surf Bio buy
Halozyme has expanded its portfolio of drug delivery technologies for a second time in a few months with the acquisition of Surf Bio for up to $400m.
pharmaphorum.com
January 29, 2026 at 9:38 AM